{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:01:31Z","timestamp":1790193691408,"version":"4.1.0"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":2184,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81070237"],"award-info":[{"award-number":["81070237"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270354"],"award-info":[{"award-number":["81270354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300213"],"award-info":[{"award-number":["81300213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Atherosclerosis is an autoimmune inflammatory disease involving both innate and adaptive immune mechanisms. Immune tolerance induction may have therapeutic potential for the suppression of atherosclerosis. Current interest is directed towards mucosal tolerance induction, especially nasal tolerance. Previous studies have shown that heat shock protein 60 (HSP60) is recognized as an important autoantigen in atherosclerosis, and nasal or oral HSP60 can induce tolerance and ameliorate atherosclerosis by inducing several subsets of regulatory T cells (Tregs) such as latency-associated peptide (LAP)+ and forkhead box transcription factor 3 (FoxP3)+ Tregs. However, little is known regarding the detailed mechanisms of nasal tolerance. Here, we again investigated the impact of nasal HSP60 on atherosclerosis and the mechanisms underlying the anti-atherosclerosis responses. We found that nasal HSP60 caused a significant 33\u00b76% reduction in plaque size at the aortic root in the early stages of atherosclerosis (P\u2009&amp;lt;\u20090\u00b7001). Notably, a significant increase in activated CD4+CD25+ glycoprotein A repetitions predominant (GARP)+ Tregs, type 1 Tregs (Tr1 cells), and CD4+CD25+FoxP3+ Tregs, as well as a marked decrease in the numbers of type 1 and 17 T helper cells was detected in the spleens and cervical lymph nodes of HSP60-treated mice. Moreover, nasal HSP60 increases the production of transforming growth factor (TGF)-\u03b2 and interleukin (IL)-10 and decreases the secretion of IFN-\u03b3 and IL-17. Interestingly, the atheroprotective role of nasal HSP60 treatment was abrogated partly by the neutralization of IL-10. Our findings show that nasal administration of HSP60 can attenuate atherosclerotic formation by inducing GARP+ Tregs, Tr1 cells and FoxP3+ Tregs, and that these Tregs maintain immune homeostasis by secreting IL-10 and TGF-\u03b2.<\/jats:p>","DOI":"10.1111\/cei.12726","type":"journal-article","created":{"date-parts":[[2015,10,10]],"date-time":"2015-10-10T01:50:01Z","timestamp":1444441801000},"page":"452-468","source":"Crossref","is-referenced-by-count":41,"title":["Intranasal immunization with heat shock protein 60 induces CD4+CD25+GARP+ and type 1 regulatory T cells and inhibits early atherosclerosis"],"prefix":"10.1093","volume":"183","author":[{"given":"Y","family":"Zhong","sequence":"first","affiliation":[{"name":"Department of Cardiology, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious and Immunological Diseases, Wuhan Children's Hospital, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"key":"2021111804090966100_cei12726-bib-0001","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"2021111804090966100_cei12726-bib-0002","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ni1437","article-title":"Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3","volume":"8","author":"Williams","year":"2007","journal-title":"Nat Immunol"},{"key":"2021111804090966100_cei12726-bib-0003","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"2021111804090966100_cei12726-bib-0004","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm014","article-title":"Activation-induced Foxp3 in human t effector cells does not suppress proliferation or cytokine production","volume":"19","author":"Allan","year":"2007","journal-title":"Int Immunol"},{"key":"2021111804090966100_cei12726-bib-0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":"Transient expression of Foxp3 in human activated nonregulatory CD4+ T cells","volume":"37","author":"Wang","year":"2007","journal-title":"Eur J Immunol"},{"key":"2021111804090966100_cei12726-bib-0006","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/eji.200838168","article-title":"Is FOXP3 a bona fide marker for human regulatory T cells?","volume":"38","author":"Roncarolo","year":"2008","journal-title":"Eur J Immunol"},{"key":"2021111804090966100_cei12726-bib-0007","doi-asserted-by":"crossref","first-page":"e2705.","DOI":"10.1371\/journal.pone.0002705","article-title":"Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression","volume":"3","author":"Wang","year":"2008","journal-title":"PLOS ONE"},{"key":"2021111804090966100_cei12726-bib-0008","doi-asserted-by":"crossref","first-page":"13439","DOI":"10.1073\/pnas.0901965106","article-title":"Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021111804090966100_cei12726-bib-0009","doi-asserted-by":"crossref","first-page":"13445","DOI":"10.1073\/pnas.0901944106","article-title":"GARP (lrrc32) is essential for the surface expression of latent TGF-beta on platelets and activated Foxp3+ regulatory T cells","volume":"106","author":"Tran","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021111804090966100_cei12726-bib-0010","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1002\/eji.200939684","article-title":"Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg","volume":"39","author":"Stockis","year":"2009","journal-title":"Eur J Immunol"},{"key":"2021111804090966100_cei12726-bib-0011","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1111\/j.1582-4934.2009.00782.x","article-title":"GARP: a key receptor controlling foxp3 in human regulatory T cells","volume":"13","author":"Probst-Kepper","year":"2009","journal-title":"J Cell Mol Med"},{"key":"2021111804090966100_cei12726-bib-0012","doi-asserted-by":"crossref","first-page":"17418","DOI":"10.1073\/pnas.0507454102","article-title":"CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor cross reactivity","volume":"102","author":"Stephens","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021111804090966100_cei12726-bib-0013","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/0961203308100511","article-title":"Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells","volume":"18","author":"Wu","year":"2009","journal-title":"Lupus"},{"key":"2021111804090966100_cei12726-bib-0014","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/1529-0131(200003)43:3<617::AID-ANR19>3.0.CO;2-B","article-title":"Reduced expression of the regulatory CD4+ T cell subset is related to Th1\/Th2 balance and disease severity in rheumatoid arthritis","volume":"43","author":"Yudoh","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2021111804090966100_cei12726-bib-0015","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.109.863431","article-title":"Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice","volume":"120","author":"Sasaki","year":"2009","journal-title":"Circulation"},{"key":"2021111804090966100_cei12726-bib-0016","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.CIR.0000089083.61317.A1","article-title":"Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice","volume":"108","author":"Mallat","year":"2003","journal-title":"Circulation"},{"key":"2021111804090966100_cei12726-bib-0017","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1159\/000358639","article-title":"Impairment of circulating CD4+CD25+GARP+ regulatory T cells in patients with acute coronary syndrome","volume":"33","author":"Meng","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"2021111804090966100_cei12726-bib-0018","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0924-2244(92)90154-O","article-title":"Is atherosclerosis an autoimmune disease?","volume":"3","author":"Wick","year":"1992","journal-title":"Trends Food Sci Technol"},{"key":"2021111804090966100_cei12726-bib-0019","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00281-009-0153-8","article-title":"Innate and adaptive immunity in atherosclerosis","volume":"31","author":"Packard","year":"2009","journal-title":"Semin Immunopathol"},{"key":"2021111804090966100_cei12726-bib-0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"2021111804090966100_cei12726-bib-0021","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrcardio.2014.91","article-title":"The role of heat shock proteins in atherosclerosis","volume":"11","author":"Wick","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2021111804090966100_cei12726-bib-0022","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.autrev.2007.01.012","article-title":"Modulation of endothelial cell damage by anti-Hsp60 autoantibodies in systemic autoimmune diseases","volume":"6","author":"Alard","year":"2007","journal-title":"Autoimmun Rev"},{"key":"2021111804090966100_cei12726-bib-0023","doi-asserted-by":"crossref","first-page":"e1000552","DOI":"10.1371\/journal.ppat.1000552","article-title":"Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin","volume":"5","author":"Cappello","year":"2009","journal-title":"PLOS Pathog"},{"key":"2021111804090966100_cei12726-bib-0024","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.molimm.2012.12.013","article-title":"Characterization of human anti-heat shock protein 60 monoclonal autoantibody Fab fragments in atherosclerosis: genetic and functional analysis","volume":"54","author":"Jang","year":"2013","journal-title":"Mol Immunol"},{"key":"2021111804090966100_cei12726-bib-0025","first-page":"1927","article-title":"Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha\/beta or gamma\/delta receptor in human atherosclerotic lesions","volume":"142","author":"Kleindienst","year":"1993","journal-title":"Am J Pathol"},{"key":"2021111804090966100_cei12726-bib-0026","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.CIR.102.1.14","article-title":"Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population","volume":"102","author":"Xu","year":"2000","journal-title":"Circulation"},{"key":"2021111804090966100_cei12726-bib-0027","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1161\/CIRCULATIONAHA.108.781856","article-title":"Elevated heat shock protein 60 levels are associated with higher risk of coronary heart disease in Chinese","volume":"118","author":"Zhang","year":"2008","journal-title":"Circulation"},{"key":"2021111804090966100_cei12726-bib-0028","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaut.2012.07.006","article-title":"Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions","volume":"39","author":"Almanzar","year":"2012","journal-title":"J Autoimmun"},{"key":"2021111804090966100_cei12726-bib-0029","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/ATVBAHA.107.151274","article-title":"Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis","volume":"27","author":"van Puijvelde","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021111804090966100_cei12726-bib-0030","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.106.615609","article-title":"Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis","volume":"114","author":"van Puijvelde","year":"2006","journal-title":"Circulation"},{"key":"2021111804090966100_cei12726-bib-0031","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cardiores.2004.01.028","article-title":"Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I","volume":"62","author":"George","year":"2004","journal-title":"Cardiovasc Res"},{"key":"2021111804090966100_cei12726-bib-0032","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11596-012-0004-z","article-title":"Establishment of nasal tolerance to heat shock protein-60 alleviates atherosclerosis by inducing TGF-\u03b2-dependent regulatory T cells","volume":"32","author":"Li","year":"2012","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"2021111804090966100_cei12726-bib-0033","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s10875-012-9699-7","article-title":"CD4+LAP+ and CD4+CD25+Foxp3+ regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE\u2212\/\u2212 mice","volume":"32","author":"Zhong","year":"2012","journal-title":"J Clin Immunol"},{"key":"2021111804090966100_cei12726-bib-0034","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/ATVBAHA.109.202671","article-title":"Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis","volume":"30","author":"Klingenberg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021111804090966100_cei12726-bib-0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0165-5728(94)00187-S","article-title":"Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor","volume":"58","author":"Ma","year":"1995","journal-title":"J Neuroimmunol"},{"key":"2021111804090966100_cei12726-bib-0036","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/01.CIR.0000029750.99462.30","article-title":"Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice","volume":"106","author":"Maron","year":"2002","journal-title":"Circulation"},{"key":"2021111804090966100_cei12726-bib-0037","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.4049\/jimmunol.0902997","article-title":"Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade","volume":"184","author":"Lu","year":"2010","journal-title":"J Immunol"},{"key":"2021111804090966100_cei12726-bib-0038","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.4049\/jimmunol.162.4.1994","article-title":"Intranasally induced immunological tolerance is determined by Characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39","volume":"162","author":"Wolvers","year":"1999","journal-title":"J Immunol"},{"key":"2021111804090966100_cei12726-bib-0039","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.177.6.3606","article-title":"B7H1-Ig fusion protein activates the CD4+ IFN-gamma receptor+ type 1 T regulatory subset through IFN-gamma-secreting Th1 cells","volume":"177","author":"Ding","year":"2006","journal-title":"J Immunol"},{"key":"2021111804090966100_cei12726-bib-0040","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1191\/0961203305lu2212oa","article-title":"Role of antiheat shock protein 60 autoantibodies in atherosclerosis","volume":"14","author":"Mandal","year":"2005","journal-title":"Lupus"},{"key":"2021111804090966100_cei12726-bib-0041","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/ATVBAHA.110.217877","article-title":"Heat shock protein 60 and immune inflammatory responses in atherosclerosis","volume":"31","author":"Grundtman","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021111804090966100_cei12726-bib-0042","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/CIRCULATIONAHA.105.547414","article-title":"Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage","volume":"112","author":"Foteinos","year":"2005","journal-title":"Circulation"},{"key":"2021111804090966100_cei12726-bib-0043","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0021-9150(96)05975-8","article-title":"Macrophage-lysis mediated by autoantibodies to heat shock protein 65\/60","volume":"128","author":"Schett","year":"1997","journal-title":"Atherosclerosis"},{"key":"2021111804090966100_cei12726-bib-0044","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2249.2000.01294.x","article-title":"T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens","volume":"121","author":"Curry","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"2021111804090966100_cei12726-bib-0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.atherosclerosis.2006.09.021","article-title":"T-cell reactivity against HSP60 relates to early but not advanced atherosclerosis","volume":"195","author":"Knoflach","year":"2007","journal-title":"Atherosclerosis"},{"key":"2021111804090966100_cei12726-bib-0046","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/01.mol.0000182532.11512.90","article-title":"Regulatory T cell responses: potential role in the control of atherosclerosis","volume":"16","author":"Mallat","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"2021111804090966100_cei12726-bib-0047","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat Med"},{"key":"2021111804090966100_cei12726-bib-0048","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cellimm.2007.01.002","article-title":"Generation of HSP60-specific regulatory T cell and effect on atherosclerosis","volume":"243","author":"Yang","year":"2006","journal-title":"Cell Immunol"},{"key":"2021111804090966100_cei12726-bib-0049","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.imlet.2009.05.007","article-title":"Nasal immunization with heat shock protein 65 attenuates atherosclerosis and reduces serum lipids in cholesterol-fed wild-type rabbits probably through different mechanisms","volume":"125","author":"Xiong","year":"2009","journal-title":"Immunol Lett"},{"key":"2021111804090966100_cei12726-bib-0050","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/STROKEAHA.108.525675","article-title":"Cardiovascular risk factors and atherosclerosis in young women: atherosclerosis risk factors in female youngsters (ARFY study)","volume":"40","author":"Knoflach","year":"2009","journal-title":"Stroke"},{"key":"2021111804090966100_cei12726-bib-0051","doi-asserted-by":"crossref","first-page":"e76186","DOI":"10.1371\/journal.pone.0076186","article-title":"GARP is regulated by miRNAs and controls latent TGF-\u03b21 production by human regulatory T cells","volume":"8","author":"Gauthy","year":"2013","journal-title":"PLOS ONE"},{"key":"2021111804090966100_cei12726-bib-0052","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1091\/mbc.e11-12-1018","article-title":"GARP regulates the bioavailability and activation of TGF-\u03b2","volume":"23","author":"Wang","year":"2012","journal-title":"Mol Biol Cell"},{"key":"2021111804090966100_cei12726-bib-0053","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/0008-5472.CAN-12-3381","article-title":"Higher frequencies of GARP(+) CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality","volume":"73","author":"Kalathil","year":"2013","journal-title":"Cancer Res"},{"key":"2021111804090966100_cei12726-bib-0054","doi-asserted-by":"crossref","first-page":"e88775","DOI":"10.1371\/journal.pone.0088775","article-title":"Impaired circulating CD4+ LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study","volume":"9","author":"Zhu","year":"2014","journal-title":"PLOS ONE"},{"key":"2021111804090966100_cei12726-bib-0055","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000369719","article-title":"Heme oxygenase-1 restores impaired GARPCD4+CD25+ regulatory T cells from patients with acute coronary syndrome by upregulating LAP and GARP expression on activated T lymphocytes","volume":"35","author":"Liu","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"2021111804090966100_cei12726-bib-0056","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"2021111804090966100_cei12726-bib-0057","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000338995","article-title":"Enhancement of the frequency and function of IL-10-secreting type I T regulatory cells after 1 year of cluster allergen-specific immunotherapy","volume":"159","author":"Lou","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"2021111804090966100_cei12726-bib-0058","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clim.2010.03.006","article-title":"Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis","volume":"136","author":"Han","year":"2010","journal-title":"Clin Immunol"},{"key":"2021111804090966100_cei12726-bib-0059","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1196\/annals.1309.031","article-title":"IL-10-producing T regulatory type 1 cells and oral tolerance","volume":"1029","author":"Battaglia","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"2021111804090966100_cei12726-bib-0060","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.coi.2009.09.011","article-title":"Regulatory T cells and inhibitory cytokines in autoimmunity","volume":"21","author":"Bettini","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"2021111804090966100_cei12726-bib-0061","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5114\/pdia.2014.40954","article-title":"Interleukin-17 in human inflammatory diseases","volume":"31","author":"Shabgah","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"key":"2021111804090966100_cei12726-bib-0062","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/08916930903510880","article-title":"Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity","volume":"43","author":"Rizza","year":"2010","journal-title":"Autoimmunity"},{"key":"2021111804090966100_cei12726-bib-0063","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-60761-869-0_21","article-title":"Transforming growth factor-beta: recent advances on its role in immune tolerance","volume":"677","author":"Mantel","year":"2011","journal-title":"Methods Mol Biol"},{"key":"2021111804090966100_cei12726-bib-0064","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/hh2201.099415","article-title":"Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ Res"},{"key":"2021111804090966100_cei12726-bib-0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF03402102","article-title":"Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice","volume":"9","author":"Caligiuri","year":"2003","journal-title":"Mol Med"},{"key":"2021111804090966100_cei12726-bib-0066","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1084\/jem.183.6.2669","article-title":"A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells","volume":"183","author":"Powrie","year":"1996","journal-title":"J Exp Med"},{"key":"2021111804090966100_cei12726-bib-0067","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1084\/jem.184.1.19","article-title":"Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells","volume":"184","author":"Groux","year":"1996","journal-title":"J Exp Med"},{"key":"2021111804090966100_cei12726-bib-0068","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.4049\/jimmunol.174.11.7368","article-title":"Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis","volume":"174","author":"Hunter","year":"2005","journal-title":"J Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12726","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12726","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/183\/3\/452\/41126022\/cei12726.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/183\/3\/452\/41126022\/cei12726.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T04:54:22Z","timestamp":1692075262000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/183\/3\/452\/6412215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":68,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,11,24]]},"published-print":{"date-parts":[[2016,2,11]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12726","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,3]]},"published":{"date-parts":[[2015,11,24]]}}}